“We are very pleased to continue our commitment to BaseLaunch. Basel has always been home to great ideas and innovation and today it is a leading life sciences hub within Switzerland and globally.”

James SabryGlobal Head of Roche Pharma Partnering

“We are delighted to join BaseLaunch as a partner in the next phase of its company building activities. The Pureos team worked closely with BaseLaunch during the Series A funding of Alentis Therapeutics and has been very impressed by the team and the quality of the selected programs.”

Klaus Breiner, PhDManaging Partner at Pureos Bioventures

“This partnership will help us identify and build relationships with potential external collaborators from throughout Europe…”

Dr. Adrian ZuercherVice President, Research Europe and Head of Plasma Protein Research, CSL Behring

“Incubators and accelerators are central to the global healthcare start-up ecosystem. We have been collaborating with BaseLaunch since launch in supporting the growth and development of early-stage biotech ventures and recognize the contribution the team has made towards achieving their goals...”

Nerida ScottHead, Johnson & Johnson Innovation

“With our involvement in the review process and funding decisions through our investment board seat, we aim to contribute to BaseLaunch‘s company creation track record and leverage AbbVie‘s expertise in translating innovative science into novel therapeutics.”

Christian SchubertVice President and Head of AbbVie Ventures, Cambridge, MA

“Our partnership with BaseLaunch strengthens our connection to European biotech innovation. By joining the investment board, we can help guide company creation and apply Takeda’s expertise in turning science into new therapies. We look forward to participating in BaseLaunch and advancing innovative medicines together.”

Alison HandleyHead of the Center for External Innovation at Takeda